TICRR and lung adenocarcinoma: TICRR has been identified as a robust prognostic biomarker in lung adenocarcinoma (LUAD) due to its involvement in critical biological processes such as immune activation, cell cycle regulation, RNA modification, and tumor energy metabolism.